Griffith Peter H. 4

What Happened
Peter H. Griffith, EVP & CFO of Amgen Inc., disposed of 5,748 shares on March 16, 2026 to satisfy a tax withholding obligation related to equity compensation. The shares were credited/valued at $366.21 each, for a total value of approximately $2,104,975. This transaction is reported under code F (payment of exercise price or tax liability).

Key Details

• Transaction date and price: March 16, 2026 — 5,748 shares at $366.21 each (total ≈ $2,104,975).
• Shares owned after transaction: Not specified in this Form 4 filing.
• Footnote: 756 of the shares were Dividend Equivalents (DEs) credited to unvested Restricted Stock Units under Amgen’s equity plan; DEs are paid out in shares on a one-for-one basis per the vesting schedule (plus cash for fractional shares).
• Filing/timeliness: Form 4 filed March 18, 2026 for a March 16 transaction — filed within the standard reporting window.

Context
This was a share surrender to cover tax obligations on equity compensation (a routine administrative disposition), not an open-market sale intended to express a view on the stock. For retail investors, tax-withholding dispositions are common after vesting and are generally less informative about insider sentiment than outright purchases.